Global burden of MASLD-IBD comorbidity from 1990 to 2021 and trend prediction to 2050
MASLD-IBD comorbidity burdens have risen globally over three decades, necessitating targeted interventions, particularly for ageing populations and high-risk regions. Gender-specific strategies will be critical for mitigating future impacts.
Authors
- Haiqiang Yao (ORCID: https://orcid.org/0000-0001-9716-0171)
- Chun‐Su Yuan (ORCID: https://orcid.org/0000-0002-0711-2342)
- Bo-Yi Jia (ORCID: https://orcid.org/0000-0002-1054-6248)
- Renyun Cui
- Haowen Sun (ORCID: https://orcid.org/0009-0000-7677-8546)
- Jin‐Yi Wan (ORCID: https://orcid.org/0000-0001-8830-2035)
- Meng Wang (ORCID: https://orcid.org/0009-0007-2843-8708)
- Xinliang Zhang (ORCID: https://orcid.org/0000-0001-8513-3328)
- Yun Xu (ORCID: https://orcid.org/0000-0002-3167-3238)
- Yanrong Huang (ORCID: https://orcid.org/0009-0001-7175-9570)
- Yuqing Yi
Institutions
- Beijing University of Chinese Medicine (CN)
- University of Chicago (US)
- Beijing Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1097/js9.0000000000003383
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35